IPA questions FAERS data interpretation in the Ohio State University study
The Indian Pharmaceutical Alliance (IPA) states that a higher rate of serious adverse events (SAEs) for drugs manufactured in…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Latest Updates
Zydus Lifesciences receives USFDA approval for Methenamine Hippurate tablets
Approval allows Zydus to manufacture and market 1-gram Methenamine Hippurate tablets in the United States
Davaindia expands in Kerala to improve access to affordable generic medicines
With over 50 stores in Kerala, Davaindia aims to expand further into Tier 2 and rural areas while promoting awareness of generic…
Alkem Laboratories launches generic Empagliflozin in India at reduced cost
Empanorm and its combinations introduced at prices approximately 80 per cent lower than innovator products
Sun Pharma to acquire Checkpoint Therapeutics in oncology deal
Transaction to expand Sun Pharma’s onco-derm portfolio with FDA-approved treatment for advanced cSCC
Glenmark USA launches Polyethylene Glycol 3350, Powder for Solution, 17 grams/capful (OTC)
It compares to the active ingredient in MiraLAX Powder for Solution, 17 grams of Bayer HealthCare
Zydus receives final USFDA approval for Ketoconazole Shampoo, 2%
Ketoconazole shampoo is an antifungal medication used to treat dandruff, fungal infections, and other skin conditions
Breaking barriers: Women in STEM lead the way
This Women’s Day, Women in STEM from Merck share trials and triumphs from their journeys and provide a message for the next…
Biocon Biologics announces positive results from Phase 3 Study of Yesintek biosimilar to Ustekinumab…
The safety profile of YESINTEK was similar to the reference product Stelara (Ustekinumab) throughout the duration of the study
India’s CRDMO sector growth potential at $22 – $25 bn by 2035: BCG-IPSO Report
Report states that India’s CRDMO sector is poised for rapid growth with strong fundamentals and global realignments, focusing on…
Revamping multi-tier distribution: Ensuring consistent availability for India’s pharma growth
Chandrachur Datta, Partner, Vector Consulting Group explores how revamping the multi-tier distribution system with a demand-driven…
Leadership evolution in India’s pharma sector in 2025
As the sector adapts to technological advancements, regulatory requirements, and increasing competition, several leadership role…
India and Belgium unite to advance RNA-based vaccines
As part of this collaboration, TechInvention is introducing Quantoom’s RNA manufacturing solutions—to India with a focus on…
Jeff Bernstein joins Parexel’s Board of Directors
Jeff Bernstein succeeds Michael Bruun as part of a planned rotation
AstraZeneca gains CDSCO approval to import SZC for treating Hyperkalaemia in adult patients
This treatment can enhance hyperkalaemia management in adults, a condition characterised by elevated potassium levels that often…
Being complacent in pharma quality: Five minutes to midnight
Dr Sumedha Nadkar, Pharma Consultant and Visiting Faculty, shares a hard-hitting article which highlights that complacency in…
Funding in pharma plummets by 85 per cent in Feb 2025
As per data provided by Tracxn, the decline in investment activity makes February 2025 one of the lowest-funded months in the past…
Belgian Economic Mission to India highlights collaborations in lifesciences sector
Bringing together leaders, researchers, and stakeholders in the life sciences sector, this event aims to showcase how Belgium and…
CDSCO launches online registration process for CROs
As per the Health Ministry, registration of CROs will become mandatory with effect from April 1, 2025
Zydus launches ANVIMO for prevention of CMV
Zydus has reduced the cost of Letermovir by 91 per cent of the innovator price. ANVIMO will be available in dosages of 240 mg and…